Free Trial
NASDAQ:BHST

BioHarvest Sciences (BHST) Stock Price, News & Analysis

BioHarvest Sciences logo
$6.92 +0.01 (+0.14%)
As of 03:59 PM Eastern

About BioHarvest Sciences Stock (NASDAQ:BHST)

Key Stats

Today's Range
$6.86
$7.14
50-Day Range
$6.10
$7.66
52-Week Range
$4.66
$7.86
Volume
3,763 shs
Average Volume
6,410 shs
Market Capitalization
$113.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.67
Consensus Rating
Buy

Company Overview

Receive BHST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter.

BHST Stock News Headlines

Trump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?
Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that you don't want to take with your retirement savings.
BioHarvest enters fragrance industry with AI edge - ICYMI
See More Headlines

BHST Stock Analysis - Frequently Asked Questions

BioHarvest Sciences' stock was trading at $6.18 at the beginning of 2025. Since then, BHST shares have increased by 12.0% and is now trading at $6.92.

BioHarvest Sciences Inc. (NASDAQ:BHST) issued its quarterly earnings results on Thursday, May, 15th. The company reported ($0.13) EPS for the quarter, topping analysts' consensus estimates of ($0.15) by $0.02. The firm earned $7.64 million during the quarter, compared to analyst estimates of $8.93 million. BioHarvest Sciences had a negative trailing twelve-month return on equity of 307.04% and a negative net margin of 31.30%.
Read the conference call transcript
.

BioHarvest Sciences' top institutional investors include Magnus Financial Group LLC (0.43%) and True North Advisors LLC (0.13%).

Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
7/18/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BHST
Previous Symbol
NASDAQ:BHST
CIK
1723464
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$15.00
Low Price Target
$12.00
Potential Upside/Downside
+97.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.91 million
Net Margins
-31.30%
Pretax Margin
-31.13%
Return on Equity
-307.04%
Return on Assets
-33.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.51
Quick Ratio
0.30

Sales & Book Value

Annual Sales
$25.19 million
Price / Sales
4.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.08 per share
Price / Book
86.50

Miscellaneous

Outstanding Shares
16,420,000
Free Float
N/A
Market Cap
$113.63 million
Optionable
N/A
Beta
0.65
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:BHST) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners